Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples